The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions
- 1 July 2015
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 42 (7) , 637-642
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Letter from the Editors: PET/MRISeminars in Nuclear Medicine, 2013
- PET-MRI Fusion in Head-and-Neck Oncology: Current Status and Implications for Hybrid PET/MRIJournal of Oral and Maxillofacial Surgery, 2012
- False-positive uptake on 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imagingClinical Radiology, 2011
- Physiology and Pathophysiology of Incidental Findings Detected on FDG-PET ScintigraphySeminars in Nuclear Medicine, 2010
- Role of FDG-PET/CT in detection of recurrent disease in colorectal cancerNuclear Medicine Communications, 2010
- Value of Retrospective Fusion of PET and MR Images in Detection of Hepatic Metastases: Comparison with 18F-FDG PET/CT and Gd-EOB-DTPA–Enhanced MRIJournal of Nuclear Medicine, 2010
- Whole-body MRI for the staging and follow-up of patients with metastasisEuropean Journal of Radiology, 2009
- MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utilityHPB, 2007
- Tumor Lesion DetectionJournal of Computer Assisted Tomography, 2005
- Accuracy of Whole-Body Dual-Modality Fluorine-18–2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Tumor Staging in Solid Tumors: Comparison With CT and PETJournal of Clinical Oncology, 2004